Indiana University researchers are collaborating on a novel approach to use neuroimaging and network modeling tools—previously developed to analyze brains of patients in the clinic—to investigate Alzheimer’s disease progression in preclinical animal models.
IU School of Medicine faculty and researchers are often featured in local, national and international news coverage. To schedule an interview with an expert or obtain photos or video for media use, contact Christina Griffiths, media relations specialist.
For nearly a decade, lecanemab has been tested in clinical trials at IU School of Medicine. The drug targets the removal of amyloid plaques in the brain—a hallmark of Alzheimer’s disease. Over the past few months, nearly a dozen patients have received the treatment, which is administered through intravenous infusions every two weeks at the IU Health Neuroscience Center in downtown Indianapolis.
Indiana University School of Medicine is expanding its training program for point-of-care ultrasound (POCUS) by investing in portable ultrasound systems for all students, residents, and fellows across seven specialties to use in curricula and patient care at the academic health center in Indianapolis.